- About us
- Join Putnam
David has experience advising pharmaceutical and biotechnology clients across multiple areas of product commercialization, with deep market access, pricing, value communication, and channel strategy expertise.
He has extensive experience across therapeutic areas, including oncology, rare disease, vaccines, and neurology. Prior to joining Putnam, David worked at Daiichi Sankyo in market access strategy for early oncology assets and at Precision Advisors, a life sciences commercialization strategy consulting firm. David earned his BA in Neuroscience and Statistics from Columbia University, where he conducted research on the neurobiology of social behavior in the Department of Psychology.